Related Experiment Video

Updated: Dec 7, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K

APS/SPR Virtual Chat: race, racism, and child health equity in academic pediatrics

Tumaini Rucker Coker1, David Keller2, Stephanie Davis3

  • 1Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, WA, USA.

Pediatric Research
|September 25, 2020
PubMed

Insights

Institutional racism is prevalent in Academic Pediatrics, impacting research, clinical work, and education. Addressing this systemic issue is crucial for achieving health equity for children, even if the process involves setbacks.

Area of Science:

  • Pediatrics
  • Health Equity
  • Social Determinants of Health

Background:

  • Institutional racism is a documented issue within Academic Pediatrics in the United States.
  • This systemic issue impacts the professional activities of researchers, clinicians, and educators in the field.

Purpose of the Study:

  • To acknowledge the existence and impact of institutional racism in Academic Pediatrics.
  • To advocate for the professional mission of all pediatric professionals to confront institutional racism.
  • To prepare for the challenges and potential failures inherent in pursuing health equity.

Main Methods:

  • This study is a conceptual analysis and position statement.
  • It draws on the lived experiences and observations of professionals within Academic Pediatrics.
  • The approach involves critical reflection on the current state of the field.

Main Results:

  • Institutional racism demonstrably affects research, clinical practice, and education within Academic Pediatrics.
  • Confronting institutional racism is identified as a necessary, albeit difficult, lifelong endeavor for all racial groups.
  • The pursuit of health equity for children necessitates acknowledging and accepting the possibility of failure.

Conclusions:

  • Addressing institutional racism must be an integral part of the professional mission in Pediatrics.
  • Achieving health equity for children in the U.S. is a complex goal that may involve setbacks.
  • Professionals in Pediatrics should not be deterred by the prospect of failure when working towards health equity.
Abstract

More Related Videos

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.9K
Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.6K

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
253
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144